RNAi Market 2017 Global Trend, Share and Opportunities Forecast To 2022

The Report Provides Essential Information Including Market Data, Segmentation, Market Size, Key Trends, M&A, Product Developments, Industry Forecasts, Corporate Intelligence, And Other Relevant Information

RNAi Industry

Description

Wiseguyreports.Com Adds “RNAi -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

RNAi Market research report covers both products and services in the RNAi industry. The global RNAi market is analyzed by Tools/Products and Applications for each of the geographic regions- North America, Europe, Asia-Pacific and Rest of World. The RNAi Tools/Products are further segmented into Design/Software (miRNA Target Scan, miRNA Analysis Software, and Design Software), Synthesis (Expression Vectors, Chemical, miRNA Isolation, Dicer/RNAseIII, and In Vitro), Delivery (Vector Based, Transfection Reagents, and Electroporation), Monitoring/Optimizing (Primers for RTqPCR, Controls, and miRNA Detection Tools), and Libraries (Human, Mouse, and Rat). Application by Research (Functional Genomics, Metabolism, and Protein Chemistry), Therapeutics (Oncology, Neurology, Ophthalmology, and Virology) and Drug Development (Target Identification, Target Validation, and Drug Mechanism) are also analyzed. Business profiles of major companies are discussed in the report.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/905702-rnai-market-research-report

The report serves as a guide to global RNAi industry Market size covering 390 plus companies that are engaged in RNAi synthesis, R&D, therapeutics, test kits, tools and services. Major Research Organizations and Universities serving the industry are also covered in the Corporate Directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Estimations and predictions are provided by geographic regions with exclusive graphical representations illustrated for 470 plus exhibits.

Highlights

The most popular subject in molecular biology and a new regulatory pattern in biology is “Gene Silencing” which is obtained by RNA interference (RNAi) or by DNA methylation process. Naturally, gene silencing acts as a gene regulator in plants and animals and pathologically inhibits genes involved in tumor suppression in cancer. Gene silencing is a way of accomplishing selective interference of gene function and loss of function screens on a genomic wide scale in functional genomics.

In the mechanism of RNA interference (RNAi), tiny small interference RNA (siRNA) are formed by the splitting of the double stranded RNA (dsRNA) which are sequence specific mediators of gene silencing. RNA interference is an extremely powerful, post transcriptional gene silencing mechanism and uses short double stranded RNA to mark messenger RNA transcripts for degradation. RNAi, a breakthrough in molecular biology, has redefined drug discovery and target ratification, and can bring a paradigm shift in the drug discovery and development process.

Exclusive 25 % flat discount (offer valid till 31st March 2017) @ https://www.wiseguyreports.com/check-discount/905702-rnai-market-research-report

Key Players

Allele Biotechnology and Pharmaceuticals, Inc. (USA) 

Alnylam Pharmaceuticals, Inc. (USA) 

Arbutus Biopharma Corporation (Canada) 

Arrowhead Research Corporation (USA) 

Asuragen, Inc. (USA) 

Benitec Ltd. (Australia) 

Bioneer Corporation (South Korea) 

Cepheid (USA) 

Clontech Laboratories, Inc. (USA) 

CytoPathfinder, Inc. (Japan) 

GlaxoSmithKline PLC (UK) 

InvivoGen (USA) 

Marina Biotech, Inc. (USA) 

Mirus Bio LLC (USA) 

Novus Biologicals, LLC (USA) 

Promega Corporation (USA) 

Qiagen N.V (The Netherlands) 

Quark Pharmaceuticals, Inc. (USA) 

Regulus Therapeutics, Inc. (USA) 

Rosetta Genomics Laboratories (Israel) 

RXi Pharmaceuticals Corporation (USA) 

Silence Therapeutics plc (UK) 

SomaGenics, Inc. (USA) 

Sylentis SA (France)

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=905702

Why buy this Report

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

  • Identify Market Opportunities
  • Review and Analyze Global and Regional Markets
  • Gauge Market Potential for your Products
  • Identify Competition
  • Use Market Research for exploring new areas
  • Acquire Meaningful Guidelines for Strategic Planning
  • Gear up for Market Entry
  • Get Actionable Information

Analytics and data presented in each report pertain to several parameters such as –

  • Global and Regional Market Sizes, Market Shares, Market Trends
  • Product (Global and Regional) Market Sizes, Market Shares, Market Trends
  • Technology Trends
  • Corporate Intelligence
  • Key Companies By Sales, Brands, Products
  • Other Strategic Business Affecting Data

Continued…                                                                                            

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US)  Ph: +44 208 133 9349 (UK)

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: sales@wiseguyreports.com
Phone: +1 646 845 9349, +44 208 133 9349
City: New York City
State: NY
Country: United States
Website: https://www.wiseguyreports.com/sample-request/905702-rnai-market-research-report